Cleared Traditional

K090556 - SPACELABS ELANCE VITAL SIGNS MONITORING...

K090556 is an FDA 510(k) clearance for SPACELABS ELANCE VITAL SIGNS MONITORING..., manufactured by Spacelabs Healthcare Medical Equipment (Suzhou) CO. The device is a Class 2 Cardiovascular device with product code MHX cleared through the Traditional 510(k) pathway after a 59-day FDA review.

K090556 · Spacelabs Healthcare Medical Equipment (Suzhou) CO · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2009
Decision
59d
Days
Class 2
Risk

K090556 is an FDA 510(k) clearance for the SPACELABS ELANCE VITAL SIGNS MONITORING SYSTEM AND CENTRAL MONITOR SOFTWARE. Classified as Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms) (product code MHX), Class II - Special Controls.

Submitted by Spacelabs Healthcare Medical Equipment (Suzhou) CO (Nederland, US). The FDA issued a Cleared decision on April 30, 2009 after a review of 59 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1025 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Spacelabs Healthcare Medical Equipment (Suzhou) CO devices

FDA 510(k) Submission Details - K090556

510(k) Number K090556 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 02, 2009
Decision Date April 30, 2009
Days to Decision 59 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
66d faster than avg
Panel avg: 125d · This submission: 59d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MHX Device Classification - Class 2, Special Controls

Product Code MHX Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1025
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MHX Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms)

All 322
Devices cleared under the same product code (MHX) and FDA review panel - the closest regulatory comparables to K090556.
DATEX-OHMEDA S/5 ANESTHESIA MONITOR WITH L-ANEO7 AND L-ANEO7A SOFTWARE USING F-CU8 OR F-CU5 (P) MONITOR FRAME OPTIONS AN
K092680 · GE Healthcare Finland Oy · Sep 2009
CARESCAPE MONITOR B850
K092027 · Ge Medical Systems Information Technologies · Aug 2009
MP5 INTELLIVUE PATIENT MONITOR
K091395 · Philips Medizinsysteme Boeblingen GmbH, Cardiac AN · Jun 2009
MODIFICATION TO DASH 2500 PATIENT MONITOR
K090702 · Ge Medical Systems Information Technologies · Apr 2009
CAPNOSTAT / CAPNOFLEX CO2 SYSTEM
K083750 · Ge Medical Systems Information Technologies · Mar 2009
FUKUDA DENSHI DYNASCOPE MODEL DS-7000 SERIES PATIENT MONITOR, MODEL DS-7000//7000M/7210/7210M
K083697 · Fukuda Denshi USA, Inc. · Mar 2009